Cim Investment Management Inc Eli Lilly & CO Transaction History

Cim Investment Management Inc

$321 Million
Q2 2024

A detailed history of Cim Investment Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cim Investment Management Inc holds 2,137 shares of LLY stock, worth $1.93 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

2,137

Previous 2,166 1.34%

Holding current value

$1.93 Million

Previous $1.69 Million 14.78%

% of portfolio

0.6%

Previous 0.51%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$724.87 - $909.04 $21,021 - $26,362	-29 Reduced 1.34%	2,137 $1.93 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $18,692 - $25,769	-43 Reduced 1.95%	2,166 $1.16 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $74,356 - $99,423	212 Added 10.62%	2,209 $1.04 Million
Q1 2023 May 16, 2023	BUY	$310.63 - $364.82 $27,335 - $32,104	88 Added 4.61%	1,997 $685,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $15,434 - $17,984	-48 Reduced 2.45%	1,909 $698,000
Q2 2022 Sep 02, 2022	SELL	$278.73 - $327.27 $554,951 - $651,594	-1,991 Reduced 50.43%	1,957 $635,000
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $938 - $1,166	-4 Reduced 0.1%	3,948 $1.13 Million
Q4 2021 May 19, 2022	SELL	$224.85 - $279.04 $904,121 - $1.12 Million	-4,021 Reduced 50.43%	3,952 $1.09 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $888,607 - $1.1 Million	3,952 Added 98.28%	7,973 $2.02 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $902,355 - $1.11 Million	-4,072 Reduced 50.32%	4,021 $929,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $41,165 - $53,247	-228 Reduced 2.74%	8,093 $1.86 Million
Q1 2021 May 20, 2021	BUY	$164.32 - $212.72 $526,316 - $681,342	3,203 Added 62.58%	8,321 $1.56 Million
Q4 2020 Feb 17, 2021	SELL	$130.46 - $172.63 $9,262 - $12,256	-71 Reduced 1.37%	5,118 $864,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $6,579 - $7,610	-45 Reduced 0.86%	5,189 $768,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $714,022 - $859,318	5,234 New	5,234 $859,000
Q1 2020 May 22, 2020	SELL	$119.05 - $147.35 $643,941 - $797,016	-5,409 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $54,676 - $59,473	-512 Reduced 8.65%	5,409 $605,000
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $655,987 - $765,703	5,921 New	5,921 $656,000
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $933,899 - $1.17 Million	-10,877 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $23,239 - $26,672	-307 Reduced 2.74%	10,877 $928,000
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $20,481 - $24,177	-276 Reduced 2.41%	11,184 $865,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $939,032 - $1.01 Million	11,460	11,460 $968,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account

Cim Investment Management Inc Eli Lilly & CO Transaction History